Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
Veids | Citi |
Valoda | EN |
Statuss | Publicēts |
Versija | |
Datums | 2016-03-14 19:07:23 |
Versijas komentārs | |
Teksts |
Recording of the Investor Conference Webinar about financial results of 2015
On March 14 AS „Olainfarm”
organized its Investor Conference Online Webinar. During the
webinar the member of the management board of AS „Olainfarm” Salvis
Lapiņš analyzed the financial results of fourth quarter 2015 and
non-audited financial results of 12 months 2015, as well as
informed about the other recent activities within the company.
During the presentation Salvis
Lapiņš noted that AS “Olainfarm” intends to pay dividends for 2015
and next few years, however considering the recent and planned
acquisitions the proposal from the management board of AS
“Olainfarm” currently would be to freeze the payout ratio at 15%
for next three years.
The recorded “Olainfarm” webinar is available online:
ej.uz/OLF_YE2015_video,
and the
presentation, demonstrated during the webinar, is available in the
attachment.
Olainfarm thanks all participants,
who joined the webinar, and encourages everybody to follow
company’s announcements to get information on the next webinar!
JSC Olainfarm is one of the
biggest pharmaceutical companies in Latvia with more than 40 years
of experience in production of medication and chemical and
pharmaceutical products. A basic principle of company's operations
is to produce reliable and effective top quality products for
Latvia and the rest of the world. Products made by the Group are
being exported to more than 35 countries of the world, including
the Baltics, Russia, other CIS, Europe, Asia, North America and
Australia Information prepared by: |
Pielikumi |